Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV-1-infected patients

HIV Med. 2017 Nov;18(10):790-792. doi: 10.1111/hiv.12523. Epub 2017 May 15.

Authors

F Rigo¹, G Cucchetto¹, M Lanzafame¹, S Nicolè¹, E Lattuada¹, E Concia¹, S Vento^{2

3}

Affiliations

¹ Infectious Diseases Unit, "G.B. Rossi" University Hospital, Verona, Italy.
² Department of Medicine, School of Medicine, Nazarbayev University, Astana, Kazakhstan.
³ Nazarbayev University Medical Center, Astana, Kazakhstan.

PMID: 28503915
DOI: 10.1111/hiv.12523

No abstract available

Publication types

Letter

MeSH terms

Adult
Atazanavir Sulfate / pharmacology
Atazanavir Sulfate / therapeutic use*
Drug Therapy, Combination
Female
HIV Infections / drug therapy*
HIV-1 / drug effects
Humans
Lamivudine / pharmacology
Lamivudine / therapeutic use*
Male
Middle Aged
Treatment Outcome

Substances

Lamivudine
Atazanavir Sulfate